SQUAWK/NEWS
Menu
Live News EQUITY L impact

AMRX TEVA favored names in generics and neutral on VTRS in Q2 preview @ GSCO

AMRX TEVA favored names in generics and neutral on VTRS in Q2 preview @ GSCO

AMRXTEVAVTRS

AMRX TEVA favored names in generics and neutral on VTRS in Q2 preview @ GSCO